Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group (Q73153245)
Jump to navigation
Jump to search
scientific article published on 01 November 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group |
scientific article published on 01 November 1999 |
Statements
Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group (English)
S Jones
C Vogel
A Arkhipov
L Fehrenbacher
P Eisenberg
B Cooper
S Honig
A Polli
F Whaley
E di Salle
J Tiffany
A Consonni